PMTS Q2 2025: Tariff Costs Climb to $5M, Margin Pressures Offset by Arrow Eye Acquisition
PMTS delivered double-digit sales growth in Q2, but rising tariffs and transition costs at its new Indiana facility materially pressured margins. The Arrow Eye acquisition outperformed initial expectations, giving PMTS entry into new verticals and helping to partially offset cost headwinds. Management raised its sales outlook for the year, but EBITDA guidance remains unchanged as margin recovery is deferred to 2026.
Summary
- Margin Headwinds Intensify: Tariff expenses and dual facility costs weigh on profitability despite strong sales execution.
- Arrow Eye Outperformance: Acquisition exceeds revenue and profit expectations, unlocking new market segments.
- Long-Term Growth Bets: Strategic investments in automation, digital, and new verticals position PMTS for expanded addressable markets.
Performance Analysis
PMTS posted 15% underlying sales growth in Q2 (excluding an $8 million one-time accounting change), led by robust performance in its debit and credit card segment and the initial contribution from the Arrow Eye acquisition. Secure card volumes and Card@Once, the company’s instant issuance software-as-a-service (SaaS) platform, both delivered record sales quarters, while open loop prepaid sales advanced on higher value tamper and packaging solutions. However, gross margin fell to 30.9% from 34.7% a year ago, as the business absorbed $1 million in quarterly tariff costs and incremental expenses from running two Indiana facilities during the transition to a new site.
Adjusted EBITDA rose 3% to $22.5 million, with the Arrow Eye contribution and sales growth helping offset lower margins. Segment analysis reveals debit and credit income from operations declined 9% in Q2, as cost inflation and unfavorable mix outpaced revenue gains. The prepaid segment was most affected by the accounting change, but still managed 4% growth ex-adjustment. Free cash flow declined slightly to $0.8 million on elevated capital spending for the Indiana facility and automation investments, while net leverage rose to 3.6x due to acquisition funding.
- Sales Mix Shift: Larger volume issuers and a decline in personalization services diluted margins even as core volumes grew.
- Tariff Impact Escalates: Full-year tariff expense is expected to reach $5 million, with profit impact partially shared with customers.
- Transition Drag: Operating dual Indiana facilities will cost $3 million in 2025, with relief expected as the new plant ramps in 2026.
Despite strong top-line momentum, PMTS faces near-term profitability constraints, with meaningful margin recovery now expected next year as cost headwinds abate and operational efficiencies materialize.
Executive Commentary
"Our customers are excited about our solutions, our business continues to grow, and our Arrow Eye acquisition is performing better than our expectations… Arrow Eye becoming a part of CPI creates many opportunities that CPI now has access to a number of additional market segments."
John Lowe, President and Chief Executive Officer
"Gross margins in the quarter were pressured by various factors… sales mix, increased production costs, higher tariffs, depreciation, and incremental costs related to our Indiana production facility transition… We are working to alleviate margin pressures for 2026 through supplier negotiations, synergies from the Arrow Eye acquisition, better contribution from our emerging digital solutions, and expected efficiencies from our advanced machinery investments."
Jeff Hoxtep, Chief Financial Officer
Strategic Positioning
1. Arrow Eye Acquisition Expands Reach
The Arrow Eye acquisition, completed in May, contributed nearly $10 million in revenue in less than two months, outperforming expectations. Arrow Eye’s customer base spans prepaid program managers, payroll providers, healthcare, fintechs, and more, with minimal overlap with PMTS’s legacy clients. This opens new verticals such as government, insurance, and fleet, diversifying PMTS’s revenue streams and providing growth runway. Synergies are expected to build in 2026 as procurement leverage and cross-selling opportunities scale.
2. Secure Card and Card@Once Momentum
The secure card business remains the core engine, with over 15% volume and sales growth in H1. Card@Once, PMTS’s SaaS instant issuance solution, expanded to 17,000+ locations, securing government disbursement programs as a new vertical. The business benefits from recurring revenue and high customer stickiness, and management is actively pursuing further penetration into non-financial institution markets.
3. Investments in Automation and Capacity
Significant capital has been allocated to automation in Colorado, workflow innovation in Tennessee, and a new state-of-the-art Indiana facility. The Indiana site is now operational, with transition peaking in the second half. Once fully ramped, management expects material efficiency gains and incremental capacity to support growth and margin recovery in 2026 and beyond.
4. Diversification into Healthcare and Closed-Loop Prepaid
PMTS is targeting healthcare payment cards and closed-loop prepaid packaging as long-term growth vectors. The company already secured its first closed-loop customer commitments for Q4 and sees healthcare as a recurring, attractive vertical, especially with Arrow Eye’s established presence. These bets diversify end-markets and reduce reliance on traditional debit and credit issuance cycles.
5. Digital and Metal Card Solutions
Digital issuance and metal card offerings are gaining traction, though still immaterial to overall sales. PMTS continues to invest in push provisioning and digital enablement for small and mid-sized financial institutions, aiming for higher margin contribution as adoption grows. Metal cards serve as a value-focused complement to premium offerings, targeting smaller issuers seeking differentiation.
Key Considerations
PMTS’s Q2 reveals a company balancing robust top-line growth with acute cost headwinds, while executing a multi-pronged strategy to diversify and automate its business model. Strategic context for the quarter centers on the tension between near-term margin erosion and long-term expansion bets.
Key Considerations:
- Tariff Volatility: Tariffs represent a $5 million annual headwind, with uncertainty around new semiconductor tariffs adding industry-wide risk.
- Operational Transition: The Indiana facility’s ramp is a drag on 2025 margins, but offers substantial future efficiency once transition costs subside.
- Acquisition Integration: Arrow Eye is outperforming early, but revenue and synergy realization will be more visible in 2026 as integration deepens.
- Sales Mix Dilution: Larger volume issuers and declining personalization services are compressing margins, requiring a pivot to higher-value products and verticals.
- Capital Allocation Discipline: Elevated capex and acquisition outlays have driven leverage higher, but management is prioritizing debt paydown as free cash flow recovers.
Risks
PMTS faces elevated risk from ongoing and potential new tariffs, especially on chips, which are the largest component of its material costs. The transition to the new Indiana facility brings operational risk and temporary cost duplication. Integration of Arrow Eye, while promising, could fall short if synergies are slower to materialize. Macroeconomic uncertainty and evolving customer order patterns could further pressure volumes or delay margin recovery.
Forward Outlook
For Q3 2025, PMTS expects:
- Continued margin pressure as Indiana facility transition costs persist
- Sales growth to accelerate in Q4 as new verticals and facility ramp contribute
For full-year 2025, management raised net sales guidance to low double-digit to mid-teens growth, incorporating Arrow Eye, while maintaining adjusted EBITDA guidance at mid to high single-digit growth. The outlook excludes potential impacts from proposed new semiconductor tariffs, with management noting ample chip inventory and industry-wide exposure. Margin improvement is expected in 2026 as cost headwinds ease and investments scale.
Takeaways
PMTS is executing on growth and diversification, but near-term profitability is constrained by tariffs and transition costs. The Arrow Eye acquisition is off to a strong start, with new verticals and synergy potential. Margin recovery and leverage reduction are deferred to 2026, with automation and digital scaling as key future levers.
- Short-Term Margin Pressure: Tariff and transition costs are likely to persist through 2025, muting EBITDA upside despite sales growth.
- Arrow Eye Integration: Early outperformance supports the acquisition thesis, but the real test will be in 2026 synergy capture and cross-selling.
- Watch for Digital and Automation Payoff: Investors should track digital solution scaling, Indiana facility ramp, and the ability to shift mix toward higher-margin products in future quarters.
Conclusion
PMTS’s Q2 underscores a business in transformation, navigating cost headwinds while expanding its reach through acquisition, automation, and new verticals. The company’s long-term growth bets are intact, but margin recovery and leverage normalization are now 2026 stories.
Industry Read-Through
The payment card manufacturing sector is facing synchronized cost inflation, with tariffs on chips and materials becoming a structural headwind. PMTS’s experience highlights the need for automation, digital enablement, and vertical diversification to defend margins and sustain growth. Industry participants should anticipate further consolidation and investment in recurring, higher-value verticals as legacy card issuance becomes increasingly commoditized. The evolving regulatory environment around tariffs will remain a key variable for all players.